ERBB2 and breast cancer: BC can be divided into four subtypes on the basis of expression of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and Ki-67 as follows: luminal A, luminal B, HER2-enriched, and triple-negative (TN).